Heated tobacco access and cigarette quitting among adult smokers
Official title: A Multi-Site Two-Arm Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Combustible Cigarette Smokers
Run by RAI Services Company · NCT07710820 · Data updated 2026-11-12
This study tests whether giving adult smokers access to a heated tobacco product helps them quit smoking by the end of 3 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 1060 (estimated) |
| Sponsor | RAI Services Company Industry-sponsored |
| Locations | 9 sites (Brandon, Florida and 8 other locations) |
| Status | Recruiting |
| Started | July 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07710820 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21–65 who smoke at least five cigarettes daily and meet screening criteria.
✕Probably not a fit
Individuals who do not respond to heated tobacco access or who have difficulty adhering to the study protocol may not quit smoking.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multi-site, open-label study comparing two heated tobacco devices with different consumable variants to see if access leads to complete abstinence from combustible cigarettes after 90 days. Eligible adults who smoke daily and meet certain criteria will use a heated tobacco product for the study duration. Participants will complete questionnaires and be monitored at research sites in Florida and Illinois. The study aims to measure the rate of end-of-study 7-day cigarette abstinence as the primary outcome.
Why it matters
Potential benefit: If successful, participants who quit smoking may experience reduced exposure to cigarette smoke and its harms.
How similar studies have gone: Some prior research on reduced-harm products has shown potential for supporting quitting in certain populations, but results vary by product and setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to read, understand, and are willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English. * Generally healthy male or female, between 21 and 65 years of age, inclusive, at the time of consent, verified with government-issued identification. * All female (assigned at birth) candidate participants who agree to take the pregnancy test on site and receive a negative result, and who affirm at the SEV that they are not pregnant or intending to become pregnant. Note: Participants who identify as "intersex" or "unknown" during screening, will be required to take a pregnancy test if they wish to take one. * Currently smoke at least five combustible cigarettes on smoking days in the past 30 days. * Smoke combustible cigarettes on 15 or more of the past 30 days. * Smoked at least 100 factory-made filtered menthol and/or non-menthol combustible cigarettes in their lifetime prior to the Site Enrollment Visit. * Must indicate a neutral/positive intention to use at least one stick variant at the Site Enrollment Visit. * Own a smartphone (iOS or Android) with internet access to download a study application to access surveys and the capability to receive notifications. * Agree to participate in the study and to abide by the study restrictions and requirements, as described in the ICF. * Must try all four stick variants during the 1-week product trial period. * Must indicate a neutral/positive intention to use at least one stick variant following the product trial period. Exclusion Criteria: * Female participants who are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report. * Male participants who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of the signing of the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children. * Female participants who self-report not using adequate methods to prevent pregnancy. * Persons with pacemakers or other embedded electronic medical devices fitted. * Participants who self-report having an unstable heart condition, severe hypertension, or diabetes. * Individuals who respond with 'Poor' or 'Don't know' to general physical or mental health. * Participants who have used electronic nicotine delivery system (ENDS), nicotine pouches, HTP or smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, other combustible tobacco/nicotine products, and other oral nicotine products (tablets, gums, and lozenges) on 5 or more days in the past 30 days. * Participants who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days. * Employee of a company that manufactures tobacco or HTPs. * Persons who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or HTPs. * Have taken part in a tobacco/nicotine research study in the past 30 days.
Where it's running
-
Opinions Brandon
Brandon, Florida, United States Recruiting -
Opinions Coral Springs
Coral Springs, Florida, United States Recruiting -
Opinions Chicago
Aurora, Illinois, United States Recruiting -
Opinions Chicago
Gurnee, Illinois, United States Recruiting -
Opinions Las Vegas
Las Vegas, Nevada, United States Recruiting -
Opinions Las Vegas
Las Vegas, Nevada, United States Recruiting
Show 3 more locations
-
Opinions Fort Worth
Fort Worth, Texas, United States Recruiting -
Opinions Houston
Houston, Texas, United States Recruiting -
Opinions Dallas
Hurst, Texas, United States Recruiting
Study contacts
- Study coordinator: Emily Smith
- Email: smithe13@rjrt.com
- Phone: 336-741-2396
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Access to multiple tobacco flavors to help adult cigarette smokers quit using e-cigarettes
This study tests whether giving adult smokers an e-cigarette with a choice of flavors helps them quit smoking by the end of 13 weeks.
-
How flavors of ENDS might help adults quit smoking their usual cigarettes
This study tests whether giving adults who smoke their regular cigarettes an electronic nicotine delivery system with different flavors can help them quit smoking their usual cigarettes after 3 months.
-
Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers
This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
-
Abuse liability and use patterns of IQOS heated tobacco among adult smokers
The study tests how appealing and user-friendly IQOS heat sticks are for adults who smoke, and compares how people puff and use IQOS versus their usual cigarettes.
-
Communal coping in couples where both partners smoke during a quit attempt
This project tests whether couples who tackle quitting as a team (communal coping) fare better when one partner in a smoking couple tries to quit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.